Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies. (Q54631945)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088848%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088848%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

0 references

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088848%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Giovanna Cenacchi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088848%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Valentina Papa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088848%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Marina Fanin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088848%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Elena Pegoraro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088848%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

19 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088848%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088848%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

258

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088848%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088848%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

746-752

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21088848%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00415-010-5823-x

16 January 2020

exact match

0 references

cites work

Clinical evaluation and management of myasthenia gravis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Seronegative myasthenia gravis: disease severity and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Clinical aspects of MuSK antibody positive seronegative MG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Muscle histopathology in myasthenia gravis with antibodies against MuSK and AChR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Are MuSK antibodies the primary cause of myasthenic symptoms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Autoimmune disorders of the neuromuscular junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

MuSK signaling at the neuromuscular junction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Anti-MuSK myasthenia gravis presenting with purely ocular findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

"Seronegative" myasthenia with antibodies against muscle-specific tyrosine-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

The features of myasthenia gravis with autoantibodies to MuSK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

MuSK-antibody positive myasthenia gravis: clinical and electrodiagnostic patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

alpha-Actinin interacts with rapsyn in agrin-stimulated AChR clustering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Myasthenia and related disorders of the neuromuscular junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5823-X

21 January 2018

1 reference

PubMed

12 December 2020

Delayed synapsing muscles are more severely affected in an experimental model of MuSK-induced myasthenia gravis

1 reference

PubMed

12 December 2020

Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures

1 reference

PubMed

12 December 2020

1 reference

12 December 2020